Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

   Case Report
    Article Figures

 Article Access Statistics
    PDF Downloaded184    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


Table of Contents   
Year : 2013  |  Volume : 6  |  Issue : 2  |  Page : 197-199
Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms

Department of Pediatrics, Division of Pediatric Cardiology, Oklahoma University Health Sciences Center, Oklahoma City, USA

Click here for correspondence address and email

Date of Web Publication20-Jul-2013


We report a case of a six-month-old Hispanic male infant who had Kawasaki disease and coronary artery aneurysms on echocardiography. He died suddenly five months later in spite of aggressive medical therapy. Autopsy showed extensive coronary artery thrombosis. Giant coronary artery aneurysms need diligent follow up as they pose significant risks including risk of thrombus, myocardial infarction and sudden death.

Keywords: Coronary thrombosis, giant coronary artery aneurysms, Kawasaki disease, sudden death

How to cite this article:
Ponniah U. Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms. Ann Pediatr Card 2013;6:197-9

How to cite this URL:
Ponniah U. Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms. Ann Pediatr Card [serial online] 2013 [cited 2022 Jan 26];6:197-9. Available from:

   Introduction Top

Kawasaki disease (KD) is an acute vasculitis of unknown cause, predominantly affecting infants and young children. Prompt diagnosis and treatment of KD within ten days of illness is critical as delayed diagnosis and treatment significantly increases the risk of coronary artery aneurysms (CAA). We report a case of six month old Hispanic male who developed giant CAA after a late diagnosis of KD and died suddenly due to extensive coronary artery thrombosis.

   Case Report Top

A six-month-old Hispanic male presented to the ER with seven-day history of fever, cough and congestion and he was treated with antibiotics for possible pneumonia. Two days later due to persistent fevers, irritability and gastrointestinal symptoms, he was admitted for septic work up. He was continued on antibiotics for possible urinary tract infection and aseptic meningitis (had elevated white cell counts in the urine and CSF). He continued to have recurrent fevers, and seventeen days into the illness he was noted to have increasing white cell count (29.5 K mm 3 ), high platelet count (1061 K mm 3 ), elevated CRP (138 mg/L), high ESR (>100 mm/hr) with mild peeling of his fingertips which prompted an echocardiogram. He had a transient conjunctivitis, dry lips and skin rash early in the course of his illness by history but had a normal exam at presentation. Echocardiogram showed extensive, multiple, giant CAA of the right coronary artery (RCA), fusiform shape, the largest measuring 19 m × 20 mm [Figure 1], the proximal left anterior descending artery (LAD) measuring 22 mm × 24 mm [Figure 2], [Video 1] and [Video 2].
Figure 1: 2D echocardiogram in the short axis view showing extensive, multiple fusiform giant CAA of the RCA (white arrows)

Click here to view
Figure 2: 2D echocardiogram in the short axis view showing giant CAA of the proximal LAD (white arrow)

Click here to view

He had a large pericardial effusion, which was drained. He was treated with IVIG and Abciximab. Due to risk of coronary artery thrombus and for myocardial protection, he was treated with enoxaparin, Clopidogrel, Aspirin, Captopril, and Propranolol, which were continued at the time of discharge. He was closely followed up as outpatient with serial echocardiograms. At his last follow up four months later, he was doing well, with stable giant CAA with no thrombus and normal biventricular function by echocardiography. A cardiac catheterization was planned in next 1-2 months.

A month later he presented to the ER with nonspecific gastrointestinal symptoms and irritability, he was presumed to have a viral illness, and was discharged. The next day he died suddenly at home. Autopsy showed giant fusiform CAA of the RCA measuring 20 mm in diameter and 65 mm in length with occluding thrombus [Figure 3]. The giant LAD aneurysm was oval and measured 20 mm in diameter and 40 mm in length with occluding thrombus [Figure 4]. The myocardium showed multifocal grayish scar formation particularly of the inter-ventricular septum suggestive of infarction. Microscopic cross section showed a completely occluding mural thrombus in RCA aneurysm with intimal wall thickening.
Figure 3: Autopsy showing multiple giant fusiform CAA of the RCA with a complete occluding thrombus

Click here to view
Figure 4: Autopsy showing giant saccular CAA of the LAD with a complete occluding thrombus

Click here to view

   Discussion Top

KD is diagnosed when there is presence of ≥ 5 days of fever and ≥ 4 of the 5 principal clinical features (rash, oral mucosa changes, conjunctivitis, extremity changes and skin rash). Patients with < 4 principal features (incomplete KD) can be diagnosed as having KD when coronary artery disease is detected by 2D echocardiography or coronary angiography. [1]

It is critical to promptly diagnose patients with KD within ten days of illness, preferably by day seven, so a highly effective treatment with IVIG and Aspirin can be initiated. CAA develops in nearly 15 to 25% of untreated patients and prompt treatment decreases the incidence to about 5% and that of giant CAA to 1%. [1] The most dreaded complication is the development of giant CAA (≥ 8 mm in diameter), which may cause stenosis, thrombosis, rupture, myocardial infarction, or sudden death. [2],[3]

The diagnosis of KD continues to be a challenge in infants as this mimics other common illnesses and drug reactions resulting in delayed diagnosis. Infants often present with incomplete criteria for diagnosis of KD as seen in our patient, which is a major factor in delayed diagnosis, and risk for CAA. [4],[5] In a multi-center study, the independent predictors of delayed diagnosis after day ten were age of < 6 months, incomplete Kawasaki disease, and greater distance from the center. [6] The late diagnosis has been attributed to wider dispersion of symptoms over time and the incidence of CAA was increased threefold in such patients. [7]

There are several risk factors for development of CAA, particularly giant CAA. Males, young infants, persistent fevers, laboratory signs of inflammation, Asian ancestry, Hispanic children (intermediate risk), longer interval to diagnosis and treatment, and recurrent disease are all at risk factors for developing CAA. [8],[9],[10] This case underscores that a high index of suspicion for KD is imperative in infants with persistent fevers, and emphasizes the need for early echocardiogram when laboratory tests for systemic inflammation are positive. [1]

Giant CAA has the highest risk for thrombosis as seen in our patient. [2],[3] In a long term follow up study; giant CAA progressed to stenosis in 46% of patients, and of these stenotic lesions, 67% developed myocardial infarction (MI) within three years. [3] The highest risk for MI is in the first year after diagnosis. [1] Sluggish flow within the aneurysms in addition to stenosis at the proximal and distal ends of aneurysms predisposes to thrombosis. [1] Despite maximal medical anticoagulation therapy, unfortunately our patient developed extensive coronary artery thrombosis nearly five months after diagnosis, which resulted in myocardial infarction and sudden death. This case further highlights that when infants with giant CAA present with irritability and nonspecific GI symptoms, a high index of suspicion and appropriate testing for coronary ischemia or myocardial infarction is necessary.

In conclusion, infants with giant CAA are at risk for thrombosis resulting in ischemia, myocardial infarction, and sudden death, and these patients require careful follow up.

   Acknowledgments Top

Dr. Choi Chai, the medical examiner in Oklahoma City, for providing the autopsy photographs. Dr. Geetha Umakumaran for help with the manuscript.

Video 1:

Video 2:

   References Top

1.Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, american heart association. Circulation 2004;110:2747-71.  Back to cited text no. 1
2.Patil S, Shirodkar S, Pinto RJ, Dalvi B. Giant coronary artery aneurysm with a thrombus secondary to Kawasaki disease. Ann Pediatr Cardiol 2008;1:59-61.  Back to cited text no. 2
3.Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85.  Back to cited text no. 3
4.Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J, 2006;25:241-4.  Back to cited text no. 4
5.Liu HC, Lo CW, Hwang B, Lee PC. Clinical manifestations vary with different age spectrums in infants with Kawasaki disease. Scientific World Journal 2012;2012:210382.  Back to cited text no. 5
6.Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, et al. Delayed diagnosis of Kawasaki disease: What are the risk factors? Pediatrics 2007;120:1434-40.  Back to cited text no. 6
7.Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: An analysis of the problem. Pediatrics, 2005;115:428-33.  Back to cited text no. 7
8.Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J 2006;25:245-9.  Back to cited text no. 8
9.Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, et al. Case-control study of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 2003;45:410-3.  Back to cited text no. 9
10.McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: Risk factors from analysis of serial normalized measurements. Circulation 2007;116:174-9.  Back to cited text no. 10

Correspondence Address:
Umakumaran Ponniah
Division of Pediatric Cardiology, Suite NP 2350, 1200 Everett Drive, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma - 73104
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-2069.115281

Rights and Permissions


  [Figure 1], [Figure 2], [Figure 3], [Figure 4]

This article has been cited by
1 Sudden death due to incomplete Kawasaki disease: A case report
Qing Zhang, Linjun Wang
Technology and Health Care. 2021; 29(2): 351
[Pubmed] | [DOI]
2 A Case of Sudden Infant Death Due to Incomplete Kawasaki Disease
Daisuke Yajima,Keiko Shimizu,Kumiko Oka,Masaru Asari,Chikatoshi Maseda,Katsuhiro Okuda,Hiroshi Shiono,Seiji Ohtani,Katsuhiro Ogawa
Journal of Forensic Sciences. 2016; 61: S259
[Pubmed] | [DOI]